Trends in US hospital admissions for skin and soft tissue infections - Wikidata - awgldk - TriplyDB

Trends in US hospital admissions for skin and soft tissue infections

Trends in US hospital admissions for skin and soft tissue infections

http://www.wikidata.org/entity/Q33644594

about

Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections Dalbavancin for the treatment of acute bacterial skin and skin structure infections Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor New developments in the management of severe skin and deep skin structure infections - focus on tedizolid Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study Bacterial Etiology and Risk Factors Associated with Cellulitis and Purulent Skin Abscesses in Military Trainees Life After USA300: The Rise and Fall of a Superbug.Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.[Hyperbaric oxygenation for necrotizing soft tissue infections: pro].Photothermal killing of Staphylococcus aureus using antibody-targeted gold nanoparticles.Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections.Correlation of Physical Exam Findings with Fever in Patients with Skin and Soft Tissue Infections Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study A Proposed New Classification of Skin and Soft Tissue Infections Modeled on the Subset of Diabetic Foot Infection.Increasing Incidence, Cost, and Seasonality in Patients Hospitalized for Cellulitis Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009 Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens Ceftaroline fosamil: a brief clinical review.A national survey of skin infections, care behaviors and MRSA knowledge in the United States.Antibacterials as adjuncts to incision and drainage for adults with purulent methicillin-resistant Staphylococcus aureus (MRSA) skin infections.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Increases in Australian cutaneous abscess hospitalisations: 1999-2008.A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Delafloxacin: design, development and potential place in therapy Role of telavancin in treatment of skin and skin structure infections Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S.Checks and balances: the ocular response to infection.Response of corneal epithelial cells to Staphylococcus aureus.Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection Monocytes loaded with indocyanine green as active homing contrast agents permit optical differentiation of infectious and non-infectious inflammation.Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.NVC-422 topical gel for the treatment of impetigo.Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates Staphylococcus lugdunensis gluteal abscess in a patient with end stage renal disease on hemodialysis.Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010

P2860

Q26746197-76675030-036F-42B0-8BAB-254EACA83D57 Q26799598-9C507214-582A-41F2-99A1-F2DACF5F0F2E Q26853612-C33DE62F-633E-40E1-80E6-2946556DF515 Q27671875-9164F161-8A60-4DAE-9EE4-5AE68B8262D2 Q28083116-59E5BE1E-D3F1-4912-BB9F-5790EB3E618A Q28384260-B52E8469-C15D-4ED0-BFEC-B794523CD934 Q28392520-73413B28-CB6D-44FC-8297-E77A11ABDD20 Q30234955-7CE23A56-4B3F-4F8E-911E-0760649D7C6A Q30251580-2668BEB2-EAE2-4379-B8DF-BDF30C4ADF49 Q30317968-E2A935D5-7351-4394-B37C-68A4FC0C3C65 Q30415264-EB46F994-659D-4A12-83C3-02447ECABE4C Q33438834-85479E14-D600-420E-ADD2-8DA3A079D3A1 Q33565355-FCDE0B76-EAC1-4CEB-B2DF-CA2390BEA61B Q33595221-02C92190-46E3-4083-9B2B-918241FF4FB8 Q33629050-66193DA0-FB31-4FB0-AC9C-782A20578A68 Q33629218-DA1FD60A-3B69-45F1-80D3-EEA5E6E37E41 Q33767148-09401800-AD9E-4362-AAF3-BB74FC035940 Q33788308-46B18A25-4F4E-4BDA-9BF7-2A25E6A14D7E Q33939080-29649F1D-B4A1-4560-B6F2-507842DD5AE8 Q34066390-AEFFEA3E-1C31-411B-AA61-B852CDA16FE5 Q34153675-DA603926-B5B3-4995-AB01-8AA16285677D Q34157657-E1B028BE-806D-4724-A393-B6F9D4A94614 Q34183562-E31CACD6-6B96-4940-BD68-BF45D0DF5DA0 Q34474973-E8A7AB05-8741-4707-8F45-6CC9285568AD Q34478074-51C8BA60-2B23-4056-B99C-D15B75ED7D6B Q34554381-B762AED0-3F21-41C5-8625-CC957EFBFF4E Q34620329-B4ADACA1-29E8-4AC1-A6A9-C3E3953E1E14 Q34672631-807A97D0-E837-460E-89F1-D807EF667C4C Q34775530-B248D748-A58C-4A39-A8E1-D89ED6EC0334 Q34775535-D87048AD-942E-49F6-82E3-5B3185D4E897 Q35017990-5072D91E-9933-4304-9A60-A6DD8168DC3E Q35055316-F01A4023-52C6-4F3C-BBD7-5ADBB9BCF62A Q35155399-A2C972C7-C6A5-466C-9524-2C9EAFA8F6A6 Q35178191-B9D59C8D-447E-4BDF-B4A6-4DF99D774412 Q35191501-8199EC43-DA64-4F13-99AF-D50E4FF0E282 Q35289810-71CD9B0C-0017-47B4-B73F-54CC271B2D12 Q35542330-F74EF816-1522-4000-8EA5-0096154A8791 Q35656230-1E8D95AB-0C9A-481D-A99F-A7020B1188BC Q35688982-7119A3A5-8EA6-42D4-A2FC-F40E5FD4D207 Q35751687-F520B403-E3D2-4977-9DBB-B73BD0E9B77B

P2860

Trends in US hospital admissions for skin and soft tissue infections

http://www.wikidata.org/entity/Q33644594

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Trends in US hospital admissions for skin and soft tissue infections

@ast

Trends in US hospital admissions for skin and soft tissue infections

@en

type

label

Trends in US hospital admissions for skin and soft tissue infections

@ast

Trends in US hospital admissions for skin and soft tissue infections

@en

prefLabel

Trends in US hospital admissions for skin and soft tissue infections

@ast

Trends in US hospital admissions for skin and soft tissue infections

@en

P1433

Q33644594-F310A1C4-1A52-41F6-B332-7C65D6E5EBBE

P1476

Q33644594-246D7A40-677A-4CD9-A583-2EC6C23C62A1

P2093

Q33644594-4DA17E0A-AA37-442D-AFA5-CD9A88BE0A78

Q33644594-4FAD69B0-FB00-418A-820A-91AEC995465B

Q33644594-52426EA9-9DA2-4E3C-9C31-D8D54FBF46B5

Q33644594-7D7BEF6C-2282-46BE-8496-6A174BB05C54

Q33644594-BC26415D-A9DC-4421-ABCE-42363A9FE365

Q33644594-C8CFC3EF-455F-41FF-98C7-EC5699136393

Q33644594-DF04F990-B3C4-4DCA-A755-EA89EE8509D6

Q33644594-E75653EB-B096-4D90-8253-D29B30F21A06

Q33644594-FD284F8A-3121-48FF-8FD8-DABF57D94B3E

P2860

Q33644594-69F7D622-61C5-46ED-8487-B5F7757F1BAB

Q33644594-91744526-B6A4-4F2D-8AE9-CF1D7501BA88

Q33644594-A98B4C75-61B0-48EC-83A3-567D0EAC55B2

Q33644594-AF1F01F2-8825-4BA4-AD4E-A2E0EA95FA03

Q33644594-AFC7A918-7840-4C99-94A0-80F44B550082

Q33644594-BE3102BE-BC25-41D0-9CD9-004752B91983

Q33644594-F3257D4F-076A-4722-B526-3FF7B54A50EF

P304

Q33644594-766B5BF1-80B3-4490-B065-D6578F2E620A

P31

Q33644594-66673D21-8BF1-431D-89B6-1BEDA7AB91E6

P356

Q33644594-F0222615-71BA-435A-9B92-AE258CF5F404

P433

Q33644594-32081267-582B-437B-95BB-B72D7202FCED

P478

Q33644594-7C57504A-88C0-49D7-AAD1-E02DED13277D

P577

Q33644594-1265551A-9AC8-45B0-A577-0D397E76C0BE

P5875

Q33644594-A6C0E36B-2F44-4496-816C-AEC7DB96F367

P698

Q33644594-2C15F8E9-5F7F-44AA-B400-F99BFE19EFF2

P932

Q33644594-683159DB-8CD1-4A5C-91B2-CDC21DC8FF38

P356

P1433

Emerging Infectious Diseases

P1476

Trends in US hospital admissions for skin and soft tissue infections

@en

P2093

Carol Moore

http://www.w3.org/2001/XMLSchema#string

Charu Taneja

http://www.w3.org/2001/XMLSchema#string

Gerry Oster

http://www.w3.org/2001/XMLSchema#string

James Spalding

http://www.w3.org/2001/XMLSchema#string

Jenny Jiang

http://www.w3.org/2001/XMLSchema#string

John Edelsberg

http://www.w3.org/2001/XMLSchema#string

Katherine Reyes

http://www.w3.org/2001/XMLSchema#string

Marcus Zervos

http://www.w3.org/2001/XMLSchema#string

Nadia Haque

http://www.w3.org/2001/XMLSchema#string

P2860

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

Methicillin-resistant Staphylococcus aureus in community-acquired skin infections

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003).

Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

P304

1516-1518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1509.081228

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26855672

http://www.w3.org/2001/XMLSchema#string

P698

19788830

http://www.w3.org/2001/XMLSchema#string

P932

2819854

http://www.w3.org/2001/XMLSchema#string